Effect of metabolic inhibitors on the formation of antibody to sheep erythrocytes, on development of delayed hypersensitivity, and on the immune response to infection with Mycobacterium tuberculosis in mice
- PMID: 415003
- PMCID: PMC414069
- DOI: 10.1128/iai.19.1.212-216.1978
Effect of metabolic inhibitors on the formation of antibody to sheep erythrocytes, on development of delayed hypersensitivity, and on the immune response to infection with Mycobacterium tuberculosis in mice
Abstract
The effect of a number of metabolic inhibitors was determined on: (i) the production of cellular immunity to infection with Mycobacterium tuberculosis in mice by vaccination with mycobacterial ribonucleic acid (RNA), (Ii) the production of cellular immunity to infection with M. tuberculosis in mice with viable H37Ra cells, (iii) the induction of antibody formation to sheep erythrocytes, and (iv) the induction of delayed hypersensitivity in mice to purified protein derivative. The pattern of inhibition produced by metabolic inhibitors on cellular immunity to infection with M. tuberculosis produced by mycobacterial RNA was entirely different from the pattern of inhibition produced by the same metabolic inhibitors on antibody formation to sheep erythrocytes. The effect of the metabolic inhibitors on the induction of delayed hypersensitivity to purified protein derivative did not correlate with the pattern of inhibition produced by the same compounds on antibody formation or on the development of immunity produced by mycobacterial RNA. Cellular immunity to infection produced in mice by viable H37Ra cells was not reduced by any of the metabolic inhibitors except actinomycin D. The possible reasons for the lack of activity of the metabolic inhibitors on the immune response to viable H37Ra cells and the lack of correlation with the pattern of inhibition found in mice vaccinated with mycobacterial RNA is discussed.
Similar articles
-
Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.Infect Immun. 1973 Jul;8(1):42-7. doi: 10.1128/iai.8.1.42-47.1973. Infect Immun. 1973. PMID: 4198103 Free PMC article.
-
Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.Infect Immun. 1976 Jan;13(1):127-32. doi: 10.1128/iai.13.1.127-132.1976. Infect Immun. 1976. PMID: 814098 Free PMC article.
-
Immunogenicity of ribonucleic acid-protein fraction of Mycobacterium tuberculosis encapsulated in liposomes.J Med Microbiol. 1989 Jun;29(2):131-8. doi: 10.1099/00222615-29-2-131. J Med Microbiol. 1989. PMID: 2471834
-
In vitro cellular and cytokine responses to mycobacterial antigens: application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines.Am J Med Sci. 1997 Jun;313(6):364-71. doi: 10.1097/00000441-199706000-00009. Am J Med Sci. 1997. PMID: 9186152 Review.
-
Immunology of tuberculosis.Med Clin North Am. 1993 Nov;77(6):1235-51. doi: 10.1016/s0025-7125(16)30190-0. Med Clin North Am. 1993. PMID: 8231409 Review.
Cited by
-
Immunoregulatory biological response modifiers: effect of cytokines on septic shock.Mediators Inflamm. 1993;2(7):S5-S10. doi: 10.1155/S0962935193000675. Mediators Inflamm. 1993. PMID: 18475571 Free PMC article.
-
Immunological responses in patients with tuberculosis and in vivo effects of acetyl-L-carnitine oral administration.Mediators Inflamm. 1993;2(7):S17-20. doi: 10.1155/S0962935193000699. Mediators Inflamm. 1993. PMID: 18475563 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources